Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 USD | -6.38% | -6.88% | -25.11% |
May. 09 | Transcript : Xeris Biopharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q1 Revenue $40.6M, vs. Street Est of $41.8M | MT |
Financials (USD)
Sales 2024 * | 184M | Sales 2025 * | 218M | Capitalization | 261M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -37M | EV / Sales 2024 * | 1.42 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.2 x |
P/E ratio 2024 * |
-4.04
x | P/E ratio 2025 * |
-7.15
x | Employees | 377 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.58% |
Latest transcript on Xeris Biopharma Holdings, Inc.
1 day | -6.38% | ||
1 week | -6.88% | ||
Current month | +0.57% | ||
1 month | -11.11% | ||
3 months | -38.68% | ||
6 months | +4.45% | ||
Current year | -25.11% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Edick
CEO | Chief Executive Officer | 67 | 21-04-30 |
Steven Pieper
DFI | Director of Finance/CFO | 47 | 21-09-30 |
John Shannon
PSD | President | 62 | 21-10-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Johnson
BRD | Director/Board Member | 66 | 21-10-04 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 21-10-04 |
Marla Persky
BRD | Director/Board Member | 68 | 21-10-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +9.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1.76 | -6.38% | 1,940,413 |
24-05-09 | 1.88 | +1.62% | 1,611,760 |
24-05-08 | 1.85 | -1.60% | 1,026,430 |
24-05-07 | 1.88 | -0.79% | 974,867 |
24-05-06 | 1.895 | +0.26% | 1,366,677 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.11% | 261M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- XERS Stock